Cosmetics & Personal Care Manufacturing Insurance

Why Cosmetics and Personal Care Manufacturers Need Specialized Insurance Coverage

This industry just underwent the most significant regulatory shift in its history. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA), in FDA's own words, is "the most significant expansion of FDA's authority to regulate cosmetics" since 1938. Before MoCRA, cosmetics were never subject to FDA pre-market approval, relying instead on a purely voluntary registration program. MoCRA changed that permanently: facility registration, product listing, mandatory serious adverse event reporting within 15 business days, and documented safety substantiation are now real federal requirements, not best practices.

The product liability exposure underneath that new framework is well documented. A peer-reviewed analysis of FDA warning letters found unapproved drug claims, cosmetics marketed with language that crosses into treating or curing a condition, were the single most common violation category, cited in over 85 percent of letters reviewed, ahead of misbranding and labeling issues. Allergic reaction and skin irritation claims, ingredient mislabeling, and contamination round out the recognized claim categories for this trade, and FDA's new mandatory recall authority under MoCRA means the agency no longer has to rely on a manufacturer's voluntary cooperation to pull a product from the market.

Products-completed operations coverage matters acutely here, since an allergic reaction or a contamination issue often doesn't surface until well after a product has reached a retail shelf and a consumer's medicine cabinet.

• MoCRA (2022) is the largest expansion of FDA cosmetics authority since 1938
• Mandatory facility registration and product listing now replace the old voluntary program
• Unapproved drug claims are the most common FDA cosmetics warning-letter violation
• Serious adverse events must be reported to FDA within 15 business days under MoCRA
• FDA now holds mandatory recall authority over cosmetics for the first time
• California's Safe Cosmetics Act layers state ingredient-disclosure rules on top of MoCRA
• Products-completed operations coverage for reactions/contamination surfacing after sale

Core Coverages for Skincare, Haircare, and Personal Care Producers

A complete program layers coverage so each exposure has a clear home. Products liability, including products-completed operations, responds to claims of allergic reaction, contamination, or mislabeling, the recognized core claim categories for this industry. Recall expense coverage funds the direct costs of a product recall, now a meaningfully more likely scenario given FDA's new mandatory recall authority under MoCRA, covering retrieval, communication with retailers, and destruction or reprocessing of affected product.

Property and equipment breakdown coverage protects filling, blending, and compounding equipment, and cyber liability addresses the data generated by MoCRA's new facility-registration and product-listing requirements, along with any consumer data your brand collects directly. Workers compensation and general liability round out the program for production staff and premises risk, and advertising injury coverage matters specifically for this trade given how closely FDA scrutinizes marketing claims that stray into drug-claim territory.

We assemble these from 15-plus A-rated carriers so the structure matches whether you produce skincare, haircare, color cosmetics, or a combined personal care product line.

• Products liability / products-completed operations for reaction, contamination, and labeling claims
• Recall expense coverage sized for FDA's new mandatory recall authority under MoCRA
• Property and equipment breakdown for filling, blending, and compounding equipment
• Cyber liability for MoCRA registration/listing data and consumer information
• Advertising injury coverage given FDA's scrutiny of unapproved drug-claim marketing
• Workers compensation for production and lab staff per state mandates
• General liability for premises and third-party bodily injury/property damage

Federal and State Regulatory Standards for This Industry

Under MoCRA, manufacturers and processors must register facilities with FDA and renew registration every two years, and the responsible person for each product must maintain a current product listing, including ingredients, updated annually. Serious adverse events, reactions involving significant disability, disfigurement, or events requiring medical intervention, must be reported to FDA within 15 business days, and new medical information received within a year of an initial report must also be reported within that same 15-day window. MoCRA also directs FDA to finalize a fragrance-allergen disclosure labeling rule, currently in active rulemaking.

Before MoCRA, the only registration mechanism was the Voluntary Cosmetic Registration Program, which FDA stopped accepting new submissions to in March 2023 as it transitioned the industry to MoCRA's mandatory Cosmetics Direct system. As of mid-2026, FDA reports well over 16,000 active facility registrations and more than 1.2 million active product listings under the new system, a real measure of how broadly this compliance shift has already reached.

State-level regulation adds a further layer that predates and continues alongside MoCRA. California's Safe Cosmetics Act, in effect since 2005, requires manufacturers to report to the state any cosmetic ingredients known or suspected to cause cancer or reproductive toxicity, an ingredient-disclosure regime that operates independently of the new federal framework. The Personal Care Products Council, the national trade association for this industry since 1894, publishes its own public policy guidance specifically addressing MoCRA compliance.

• Facility registration and biennial renewal are now mandatory under MoCRA
• Product listings, including ingredients, require annual updates per responsible person
• Serious adverse events must reach FDA within 15 business days of report or new information
• FDA's fragrance-allergen disclosure rulemaking is active and directly tied to MoCRA
• The old Voluntary Cosmetic Registration Program closed to new submissions in March 2023
• Over 16,000 facilities and 1.2 million product listings are registered under MoCRA as of mid-2026
• California's Safe Cosmetics Act (2005) adds an independent state ingredient-disclosure layer

Why Personal Care Manufacturers Choose The Allen Thomas Group

The Allen Thomas Group is an independent, family-owned insurance agency founded in 2003 and licensed in 28 states. We are not tied to a single carrier, which means our advice is built around your facility's actual MoCRA compliance status and product mix, rather than a generic manufacturing template built before this regulatory shift happened.

Our advisors compare programs across 15-plus A-rated carriers and explain the trade-offs in plain language: how recall expense coverage should scale now that FDA holds mandatory recall authority, where advertising injury coverage picks up marketing-claim risk a standard products liability policy won't touch, and which endorsements matter for a brand selling into California's additional disclosure regime. The agency holds an A+ rating with the Better Business Bureau, and we treat each renewal as a review rather than an auto-renewal, adjusting coverage as your product lines and distribution footprint grow.

Above all, we act as your advocate. When a claim or a recall arrives, you are dealing with people who understand this industry's new compliance reality, not a call-center queue.

• Independent, family-owned agency founded in 2003 and licensed in 28 states
• Access to 15-plus A-rated carriers for genuine program comparison
• A+ rating with the Better Business Bureau
• Advisory, consultative guidance built around your facility's MoCRA compliance status
• Annual coverage reviews that scale with product lines and distribution footprint
• Hands-on claims advocacy during a recall or products liability event
• Deep experience structuring programs for regulated consumer product manufacturing

How Much Does Cosmetics and Personal Care Manufacturing Insurance Cost?

There is no single published rate for this category, because pricing depends on your product mix (leave-on versus rinse-off products carry different exposure profiles), production volume, claims history, and whether your marketing claims stay clearly within cosmetic territory or venture closer to drug-like language FDA actively scrutinizes. A brand selling primarily into states with added disclosure regimes like California may also face different underwriting questions than one selling in states without that extra layer.

Recall expense coverage now deserves closer attention given FDA's mandatory recall authority under MoCRA, since the agency's ability to compel a recall changes the realistic probability underwriters assign to this scenario. Because every variable shifts the total, the only accurate figure comes from comparing real quotes across carriers, which is the exercise our advisors run for each brand and facility.

• Product mix (leave-on vs. rinse-off, formulation complexity) affects underwriting
• Production volume and distribution footprint are significant premium drivers
• Claims and adverse-event-report history materially affect pricing
• Marketing-claim risk (how close language comes to unapproved drug claims) factors into pricing
• Recall expense pricing should reflect FDA's new mandatory recall authority under MoCRA
• Multi-state distribution into states with added disclosure regimes adds complexity
• Comparing real quotes across carriers is the only reliable way to see your actual number

Risk Management for Cosmetics and Personal Care Facilities

Maintain your MoCRA facility registration and product listings current on their required renewal cycles, since a lapse is now a direct compliance failure, not just an administrative oversight. Build a serious-adverse-event reporting process that can genuinely meet the 15-business-day window, since the clock starts the moment your responsible person becomes aware, not when an investigation concludes.

Review every marketing claim against the line between describing a cosmetic's cosmetic effect and making an unapproved drug claim, since this remains the single most commonly cited violation category in FDA's own enforcement data. If you sell into California or other states with their own ingredient-disclosure regimes, maintain that reporting as a genuinely separate compliance track from your MoCRA obligations, not an assumed extension of federal compliance.

Finally, document safety substantiation for every formulation before it ships, since MoCRA requires manufacturers to maintain adequate safety substantiation records, and that documentation is often the first thing requested if a reaction or contamination claim is ever disputed.

• Keep MoCRA facility registration and product listings current on required renewal cycles
• Build a reporting process that can genuinely meet the 15-business-day adverse-event window
• Review every marketing claim against the cosmetic-versus-drug-claim line before publishing
• Treat state disclosure regimes (California and others) as separate from MoCRA compliance
• Document safety substantiation for every formulation before it ships
• Monitor FDA's fragrance-allergen labeling rulemaking as it finalizes
• Review the full program annually as product lines and distribution footprint change